Все публикации

0:05:24

HCV+ kidney transplantation

0:05:23

ANCA-Associated Vasculitis 2024

0:05:56

APOL1-Mediated Kidney Disease in Autoimmune Conditions

0:24:51

Welcome Address by Dr. Ali Poyan Mehr | GlomCon Hawaii 2024

0:05:12

Equity in Kidney Transplantation

0:01:57

Emerging Therapeutics for APOL1-Mediated Kidney Disease

0:58:31

C3G and Primary IC-MPGN: Complement System Driven Glomerulopathies

0:33:35

Beyond RAS Blockade: Dual Endothelin and Angiotensin Receptor Antagonism

0:51:23

A Novel Approach to the Treatment of IgA Nephropathy

0:49:17

Atacicept; A Novel Inhibitor of BAFF and APRIL In Development for the Treatment of IgAN

0:05:54

Updates in Membranous Nephropathy

0:05:13

Obesity-Related Glomerulopathy and Diabetic Nephropathy: Similarities and Differences

0:06:02

Biopsy or Not Biopsy in Patients with Diabetes and Kidney Disease

0:05:17

Update on Treatment of ANCA-associated Vasculitis and Future Perspectives

0:19:59

The ADVOCATE Trial: A Conversation with Dr. Peter A. Merkel

0:05:12

Genetic Evaluation of Living Donor Candidates

0:05:19

Not Everything Under One Umbrella

0:05:19

Tissue Transcriptomics in Kidney Transplant Rejection — Continued Surprises

0:06:15

What is really causing disparities in access to kidney transplantation?

0:06:01

Review of Rituximab-Related Complications: A Closer look at a familiar tool

0:05:17

Reaching for “Primary FSGS” & studying their disease journey within a diverse population in the USA

0:15:26

APOL1 Mediated Kidney Disease: A Conversation with Dr. Kirk Campbell

0:06:15

Focal and Segmental Glomerulosclerosis: A Need for Better Phenotyping Patients

0:05:58

Prophylaxis in Glomerular Disease